Intercept Pharmaceuticals ICPT reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Intercept Pharmaceuticals beat estimated earnings by 69.2%, reporting an EPS of $7.8 versus an estimate of $4.61.
Revenue was down $15.24 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.21 which was followed by a 13.08% increase in the share price the next day.
Here's a look at Intercept Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | -0.90 | -1.10 | -1.09 |
| EPS Actual | -0.25 | -0.58 | -1.23 | -0.63 |
| Revenue Estimate | 95.72M | 90.49M | 92.38M | 83.02M |
| Revenue Actual | 71.76M | 88.58M | 92.40M | 92.83M |
To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
